Zentalis Pharmaceuticals, Inc. (ZNTL): 6 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 8, 2026 | Walters William Thurman TenPercentOwner | 6,459,973 | $1.20 | $7.8M | no history |
| Apr 30, 2025 | Myers Scott Dunseth Director | 21,000 | $1.40 | $29.4K | no history |
| Feb 12, 2025 | Bruns Ingmar Officer | 20,000 | $2.28 | $45.6K | no history |
| Feb 4, 2025 | Eastland Julia Marie Director, Officer | 28,500 | $1.73 | $49.3K | no history |
| Feb 4, 2025 | Walker Luke Nathaniel Director | 14,200 | $1.76 | $25.0K | no history |
| Feb 4, 2025 | Skvarka Jan Director | 60,000 | $1.72 | $103.2K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.